Awinsa Life Sciences

Princeton, United States
Serves as a CRO specializing in pharmacovigilance services.

About Awinsa Life Sciences

Awinsa Life Sciences is a Healthcare company based in Princeton (United States). It serves as a CRO specializing in pharmacovigilance services. It operates on a B2B model. The company has 42 employees. Its Indian entity Awinsa Life Sciences Private Limited reported revenue of β‚Ή21.69 Cr. Its focus areas include Life Sciences, Clinical Research and Pharmacovigilance. Its competitors include Generable, Cognigen and Revolution Medicine; 1 of its 3 listed competitors has raised funding.

Company details

Awinsa Life Sciences serves as a cro specializing in pharmacovigilance services, focusing on providing healthcare solutions, life sciences, clinical research, and pharmacovigilance. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Princeton, United States
  • Employees 42
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website awinsals.com
  • Social LinkedIn X Facebook
  • Legal Name Awinsa Life Sciences Private Limited
  • Date of Incorporation 17 Apr, 2018
  • Jurisdiction Delhi, India
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹21.69 Cr

    FY 2024 · +33% YoY

  • Indian entity net profit
    ₹6.84 Cr

    FY 2024 · 32% margin

  • Indian entity EBITDA
    ₹9.61 Cr

    FY 2024 · 44% margin

  • Employee Count
    42

Board of directors of Awinsa Life Sciences Private Limited (Awinsa Life Sciences)

Awinsa Life Sciences Private Limited is the primary company behind Awinsa Life Sciences. The board of Awinsa Life Sciences Private Limited currently have 2 directors; the longest-serving is Mugdha Chopra, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Mugdha Chopra
DIN 08112286
Director17 Apr 20188 yrs 7 moAwinsa Life Sciences Private Limited
Sanjeev Kumar Miglani
DIN 08112285
Director17 Apr 20188 yrs 7 moAwinsa Life Sciences Private Limited

People of Awinsa Life Sciences

27 people are tracked at Awinsa Life Sciences (3 in leadership, 24 in team); the tracked headcount is 42.

NameRoleGroup
Arun Ram M.D.
Director - Medical Affairs And PharmacovigilanceLeadership
Founder and DirectorLeadership
Megna Bali
Sr. General Manager Quality And ComplianceLeadership
Parul Nagpal
Pharmacovigilance ManagerTeam
Chanchal Yadav
Team Lead PharmacovigilanceTeam
Sandhya G
Pharmacovigilance AssociateTeam
Snigdha Banerjee
Senior Pharmacovigilance And Medical Information AssociateTeam
Tanya Rai
Senior Pharmacovigilance AssociateTeam
Dr Sumanth Sai Panjala
Senior Safety PhysicianTeam
Shipra Singh
Senior Manager PharmacovigilanceTeam
Saranya P M
Pharmacovigilance SpecialistTeam
Dr. Soumyaa Agrawal
Senior Pharmacovigilance And Medical Information AssociateTeam
Dr Samrutha L (BDS.,AD-CRPV)
Senior Pharmacovigilance AssociateTeam
Payal Balouria
Team Lead PVTeam
Mahalaxmi Kombiah
Senior Pharmacovigilance And Medical Information AssociateTeam
Kishore Draksharam M.D.
Drug Safety PhysicianTeam
Radhika Bansal
Team LeadTeam
Raghu Badri
Senior Pharmacovigilance AssociateTeam
Malvika Jain
Senior Pharmacovigilance AssociateTeam
Prerna Kumari
Team Lead PharmacovigilanceTeam

7 more people are available in the full profile.

Premium access

Complete people profiles for Awinsa Life Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Awinsa Life Sciences

Figures of Awinsa Life Sciences Private Limited, the primary company behind Awinsa Life Sciences, for FY 2024. Revenue was ₹21.69 Cr (+33% year on year). Net profit was ₹6.84 Cr (32% margin). EBITDA was ₹9.61 Cr (44% margin). Revenue has grown at a compounded annual rate of +33% over three years and +40% over five years.

  • ₹21.69 CrRevenue · FY 2024 · +33% YoY
  • ₹6.84 CrNet profit · 32% margin
  • ₹9.61 CrEBITDA · 44% margin
  • ₹6 LakhPaid-up capital
  • 42Employees (provident fund records)
  • +33%Revenue CAGR, 3 years
  • +40%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Awinsa Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Awinsa Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Awinsa Life Sciences

Awinsa Life Sciences has 3 listed competitors in our database, 1 of them funded. They include Generable, Cognigen and Revolution Medicine.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
generable.com2016New York, United States$120,000
Precision medicine is delivered via statistical machine learning models.
cognigen.com1992Buffalo, United States
Strategic clinical pharmacology and pharmacometric consulting services are provided.
revolutionmedicine.com2014Orlando, United States181
Delivers comprehensive pharmacogenomic testing services for personalized medical solutions.
Premium access

Detailed competitors of Awinsa Life Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Toxicology

3 companies that operate in the same segment as Awinsa Life Sciences (Toxicology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Awinsa Life Sciences

Awinsa Life Sciences is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.

Awinsa Life Sciences has 42 employees.

The primary company behind Awinsa Life Sciences, Awinsa Life Sciences Private Limited, reported revenue of β‚Ή21.69 Cr for FY 2024, up 33% year on year.

Awinsa Life Sciences serves as a cro specializing in pharmacovigilance services, focusing on providing healthcare solutions, life sciences, clinical research, and pharmacovigilance. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Awinsa Life Sciences's top competitors include Generable, Cognigen and Revolution Medicine.

Awinsa Life Sciences operates through Awinsa Life Sciences Private Limited.

The legal entities of Awinsa Life Sciences currently have 2 directors, including Mugdha Chopra, Sanjeev Kumar Miglani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available